Health Canada drug identification number

DIN 02282224 — BARACLUDE 0.5 MG

BARACLUDE is a tablet of Entecavir marketed by BRISTOL-MYERS SQUIBB CANADA. The full Entecavir monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02282224
Brand name
BARACLUDE
Active ingredient
Entecavir
Strength
0.5 MG
Dosage form
TABLET
Route
ORAL
Manufacturer
BRISTOL-MYERS SQUIBB CANADA
Health Canada status
MARKETED
Drug class
Nucleoside analogue reverse transcriptase inhibitor (antiviral)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Entecavir products

DINBrandStrengthFormManufacturerStatus
02479907 ACCEL-ENTECAVIR 0.5 MG TABLET ACCEL PHARMA INC MARKETED
02396955 APO-ENTECAVIR 0.5 MG TABLET APOTEX INC MARKETED
02448777 AURO-ENTECAVIR 0.5 MG TABLET AURO PHARMA INC MARKETED
02527154 ENTECAVIR 0.5 MG TABLET SANIS HEALTH INC MARKETED
02453797 ENTECAVIR TABLETS 0.5 MG TABLET STRIDES PHARMA CANADA INC MARKETED
02467232 JAMP ENTECAVIR 0.5 MG TABLET JAMP PHARMA CORPORATION MARKETED
02485907 MINT-ENTECAVIR 0.5 MG TABLET MINT PHARMACEUTICALS INC MARKETED
02430576 PMS-ENTECAVIR 0.5 MG TABLET PHARMASCIENCE INC MARKETED
02430584 PMS-ENTECAVIR 1 MG TABLET PHARMASCIENCE INC MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.